An Exploratory Comparative Pilot Study to Identify the Most Appropriate Method for Microbial Consortia Sampling From the Skin-II
| Registry | NCT03242577 |
|---|---|
| Status | Completed |
| Study type | Observational |
| Enrollment | 10 (Actual) |
| Sponsor | Kimberly-Clark Corporation (Industry) |
| Conditions | Dermatitis |
| Dates | start 2017-08-01, primary completion 2017-08-02, completion 2017-08-02, first posted 2017-08-08, last updated 2017-11-01 |
| Locations | 1 site in United States |
Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Dermatitis
This is a single-center, exploratory comparative pilot study to identify the most appropriate method for microbial consortia sampling from the skin.
Ten subjects are expected to complete the study at one investigative site in the United States.
The study will consist of 2 visits, Visit 1 (Screening), Visit 2 (Sampling). At Visit 1, subjects will be consented and have their eligibility reviewed. Visit 1 and Visit 2 may be combined into one visit. Visit 1 will involve the informed consent process, screening, and enrollment. Visit 2 will involve sampling of eight (8) test sites on the back with three (3) different sampling methods: swabbing (2 sites/method), cup scrub (2 sites/method), and tape stripping (4 sites/method). All samples will be returned to Kimberly Clark then sent to a laboratory for analysis.
Sex: Female, ages: 18 Years to 40 Years
Inclusion Criteria: * Fluent in English, willing and able to read, understand, and sign the informed consent form (ICF); * Ability to complete the course of the study and comply with instructions; * Females aged 18 to 40 years, in good general health as deemed by the investigator (no physical required); * Individuals free of any systemic or dermatological disorder, tatoos in the testing area or recent tanning bed exposure * Anticipated ability to complete the course of the study and to comply with instructions; * Females practicing an acceptable method of birth control * Caucasian individuals with Fitzpatrick skin type I, II, or III
| Facility | City | Country | Status |
|---|---|---|---|
| Reliance Clinical Testing Services | Irving, Texas | United States |